These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3026616)

  • 21. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of localized hyperthermia on TA3Ha tumor transplanted subcutaneously in the tails of mice.
    Murthy MS; Keer HN; Travis JD; Cohen JD; Mollick JA; Khandekar JD; Scanlon EF
    Cancer Res; 1984 Sep; 44(9):3836-40. PubMed ID: 6744300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined effect of cis-DDP (II), OK-432 and systemic hyperthermia in ascites tumor in mice].
    Komatsu K; Nakamura W
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):626-37. PubMed ID: 2504850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of cisplatin-induced toxicity by selected dithiocarbamates.
    Walker EM; Fazekas-May MA; Heard KW; Yee S; Montague D; Jones MM
    Ann Clin Lab Sci; 1994; 24(2):121-33. PubMed ID: 8203821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):79-87. PubMed ID: 9464333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model.
    Zagozdzon R; Stokłosa T; Gołab J; Giermasz A; Dabrowska A; Lasek W; Jakóbisiak M
    Anticancer Res; 1997; 17(6D):4493-8. PubMed ID: 9494557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of separate administration of low-dose CDDP on antitumor immune reactivity for treatment of malignant glioma].
    Nishihara T; Tanaka S; Murakami M; Hirakawa M; Nagashima T
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1197-202. PubMed ID: 7661572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model.
    Keane TE; Gingrich JR; Rosner G; Webb KS; Poulton SH; Walther PJ
    Cancer Res; 1994 Jan; 54(2):475-81. PubMed ID: 8275484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
    Uchida J; Satake H; Saito H; Nakano K; Takeda S; Unemi N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1001-8. PubMed ID: 8210249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma.
    Ikeda H; Nakano G; Nagashima K; Sakamoto K; Harasawa N; Kitamura T; Nakamura T; Nagamachi Y
    Cancer Res; 1987 Jan; 47(1):231-4. PubMed ID: 3791210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
    J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
    Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
    Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
    Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
    Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.